Quantitative analysis for Bausch + Lomb Corporation (BLCO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (53.0) (grade C). 29 signals analyzed (24 differentiated alt-data).
BLCO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $16.00 | $15.68 | $15.72 |
| 2026-05-08 | $16.31 | $15.66 | $16.18 |
| 2026-05-20 | $16.34 | $16.05 | $16.20 |
| 2026-06-02 | $15.36 | $14.94 | $14.98 |
| 2026-06-12 | $15.44 | $15.04 | $15.08 |
| 2026-06-25 | $16.03 | $15.64 | $15.91 |
| 2026-07-08 | $16.99 | $16.38 | $16.66 |
| 2026-07-20 | $16.27 | $15.85 | $15.98 |
| 2026-07-30 | $17.01 | $16.00 | $16.99 |
| 2026-08-12 | $16.89 | $16.28 | $16.76 |
| 2026-08-24 | $17.56 | $17.22 | $17.32 |
| 2026-09-03 | $18.27 | $17.77 | $18.14 |
How Bausch + Lomb Corporation stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| BLTE | Belite Bio, Inc | $5.7B | — |
| CNTA | Centessa Pharmaceuticals plc | $6.2B | — |
| LEGN | Legend Biotech Corporation | $5.2B | — |
| STVN | Stevanato Group S.p.A. | $4.8B | — |
View all Health Care stocks by valuation and signals →
Bausch + Lomb Corporation (BLCO) scores Hold (53.0), and the composite conceals a 75-point disagreement between its dimensions. It is strongest on technicals at 84, and weakest on ML forecast at 32 and analyst consensus at 9. A stock can carry technicals that high while analyst consensus sits at 9; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 84 |
| competitive moat | 51 |
| ML forecast | 32 |
| analyst consensus | 9 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Bausch + Lomb Corporation (BLCO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/BLCO"><img src="https://stoquant.com/badge/BLCO.svg" alt="Bausch + Lomb Corporation (BLCO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.